The benzodiazepine receptor: properties and significance for pharmacology, psychiatry and neurology
Müller, W.E.
Medizinische Monatsschrift für Pharmazeuten 4(6): 174-184
1981
ISSN/ISBN: 0342-9601 PMID: 6264278 Document Number: 176848
Document emailed within 1 workday
Related Documents
Freeman, J.W. 2014: Extenuating circumstances anti-NMDA receptor encephalitis: a cautionary tale for neurology, psychiatry and the rest of us South Dakota Medicine: the Journal of the South Dakota State Medical Association 67(11): 473-474Ehlert, F.J.; Roeske, W.R.; Yamamura, S.H.; Yamamura, H.I. 1983: The benzodiazepine receptor: complex binding properties and the influence of GABA Advances in Biochemical Psychopharmacology 36: 209-220
Andronati, S.A.; Chepelev, V.M.; Iakubovskaia, L.N.; Val'dman, A.V.; Voronina, T.A. 1983: Relationship between the structure, affinity to benzodiazepine receptors and properties of 5-halogenophenyl-1,2-dihydro-3H-1,4- benzodiazepine-2-ones Bioorganicheskaia Khimiia 9(10): 1357-1361
Squires, R.F.; Klepner, C.A.; Benson, D.I. 1980: Multiple benzodiazepine receptor complexes: some benzodiazepine recognition sites are coupled to GABA receptors and ionophores Advances in Biochemical Psychopharmacology 21: 285-293
Gallager, D.W.; Wilson, M.A. 1988: Chronic benzodiazepine agonist exposure: comparison of electrophysiological changes by brain region and benzodiazepine receptor ligand Advances in Biochemical Psychopharmacology 45: 325-336
Balunov, O.A.; Malakhov, B.B.; Petrova, R.P.; Ivanov, P.P. 1984: Occupational therapy in psychiatry and neurology Meditsinskaia Sestra 43(4): 24-28
Knoflach, F.; Drescher, U.; Scheurer, L.; Malherbe, P.; Mohler, H. 1993: Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes Journal of Pharmacology and Experimental Therapeutics 266(1): 385-391
Benoliel, T.; Ben-Hur, T.; Vaknin-Dembinsky, A. 2019: Autoimmune Encephalitis: a Bridge between Neurology and Psychiatry Harefuah 158(6): 361-366
Lugoji, G. 1987: Neuropeptides--clinicobiological implications in neurology and psychiatry Neurologie et Psychiatrie 25(1): 3-14
Denisov, I.N. 1989: Perestroika in neurology, psychiatry and narcology at the present-day stage Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 89(5): 3-10
Lett, C.R. 1981: A distant man: an examiner for the American Board of Psychiatry and Neurology Journal of the National Medical Association 73(8): 763
Asami, Y.; Otsuka, M.; Hirohashi, T.; Inaba, S.; Yamamoto, H. 1974: The synthesis and pharmacology of a novel benzodiazepine derivative, 1-methyl-5-(o-fluorophenyl)-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one(ID-540) Arzneimittel-Forschung 24(10): 1563-1568
Granov, A.M.; Tiutin, L.A.; Stanzhevskiĭ, A.A. 2012: The application of nuclear medicine imaging in neurology, neurosurgery and psychiatry Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 9: 13-18
Fishman, R.A. 1977: Excerpts from president's address. The American Board of Psychiatry and Neurology Neurology 27(11): 1003-1005
Odinak, M.M.; Shamreĭ, V.K.; Chudinovskikh, A.G.; Goncharenko, A.Iu.; Tsygan, N.V. 2013: Stages of formation and development of the national military neurology and psychiatry Voenno-Meditsinskii Zhurnal 334(12): 59-67
Presecki, P.; Mimica, N. 2007: Involuntary emotional expression disorder - new/old disease in psychiatry and neurology Psychiatria Danubina 19(3): 184-188
Milling, R.N.; Lobel, M.A. 2005: 100 years of psychiatry and neurology in The Journal of the South Carolina Medical Association Journal of the South Carolina Medical Association 101(7): 248-255
Vataja, R.; Leppävuori, A. 2012: Assessment and treatment of conversion disorder: the most fascinating borderline of psychiatry and neurology Duodecim; Laaketieteellinen Aikakauskirja 128(6): 634-641
Falkai, P.; Schmauss, M. 2001: Public press commitment of the DGPPN (German Society of Psychiatry, Psychotherapy and Neurology Der Nervenarzt 72(5): 391
Anzini, M.; Cappelli, A.; Vomero, S.; Botta, M.; Cagnotto, A. 1990: 5-HT and benzodiazepine receptor ligands. III. Synthesis and receptor affinities of 1,2,4-triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one derivatives Farmaco 45(11): 1169-1179